You are currently accessing Global Competition Review via your firmwide account.
If you would like to login via a personal account, please use the link below. Log in
05 February 2020
Korea’s competition watchdog has cleared Danaher’s acquisition of General Electric’s biopharma business, but required divestiture of assets related to eight products.
View all events
Copyright © Law Business Research
Company Number: 03281866 VAT: GB 160 7529 10